The administration of azithromycin to children having poorly controlled asthma resulted in better control and reduced exacerbations, showed recent trials by researchers from the Division of Paediatric Pulmonology and Intensive Care at All India Institute of Medical Sciences, New Delhi. The study, published in the CHEST journal, analysed 120 children with an average age of 9.9 years, to find that the number of children with well controlled-asthma was 41/56 versus 10/56 in the azithromycin and control groups respectively. Oral azithromycin, when added to standard treatment, significantly reduced asthma exacerbations in children, the report said.